OpenURL Connection Search

Select item for more details and to access through your institution.

Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas.
Published in:
British Journal of Haematology, 2024, v. 204, n. 5, p. 1752, doi. 10.1111/bjh.19280
By:
- Fardella, E.;
- Zanirato, G.;
- Magni, M.;
- Caldarelli, N.;
- Chiappella, A.;
- Dodero, A.;
- Ljevar, S.;
- Orsucci, L.;
- Re, A.;
- Usai, S. V.;
- Stefoni, V.;
- Castellino, C.;
- Rossi, F. G.;
- Pinto, A.;
- Carniti, C.;
- Corradini, P.
Publication type:
Article
RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS: PLANNED SUBSET ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY.
Published in:
Hematological Oncology, 2023, v. 41, p. 104, doi. 10.1002/hon.3163_65
By:
- Thieblemont, C.;
- Lamy, T.;
- Tani, M.;
- Krzisch, D.;
- Reda, G.;
- Tedeschi, A.;
- Usai, S. V.;
- Guarini, A.;
- Bijou, F.;
- Stathis, A.;
- Anastasia, A.;
- Devizzi, L.;
- Luminari, S.;
- Arcaini, L.;
- Casasnovas, O.;
- Gressin, R.;
- André, M.;
- Houot, R.;
- Bonomini, L.;
- Zucca, E.
Publication type:
Article
Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL).
Published in:
Hematological Oncology, 2023, v. 41, p. 408, doi. 10.1002/hon.3164_300
By:
- Iannitto, E.;
- Balzarotti, M.;
- Martelli, M.;
- Zinzani, P.;
- Tucci, A.;
- Di Rocco, A.;
- Cavallo, F.;
- Usai, S. V.;
- Guidetti, A.;
- Ravano, E.;
- Merli, F.;
- Botto, B.;
- Pelosini, M.;
- Tecchio, C.;
- Spina, M.;
- Derenzini, E.;
- Finotto, S.;
- Mola, B.;
- Pinto, A.;
- Zanni, E.
Publication type:
Article
A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY.
Published in:
Hematological Oncology, 2023, v. 41, p. 48, doi. 10.1002/hon.3163_19
By:
- Davies, A. J.;
- Zucca, E.;
- Ceriani, L.;
- Kryachok, I.;
- Ciccone, G.;
- Botto, B.;
- Balzarotti, M.;
- Tucci, A.;
- Rusconi, C.;
- Usai, S. V.;
- Pennese, E.;
- Arcaini, L.;
- Dabrowska‐Iwanicka, A.;
- Ferreri, A. J. M.;
- Merli, F.;
- Zhao, W.;
- Hodgson, D.;
- Rigacci, L.;
- Cellini, C.;
- Stelitano, C.
Publication type:
Article
RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.80_2879
By:
- Luminari, S.;
- Galimberti, S.;
- Versari, A.;
- Tucci, A.;
- Boccomini, C.;
- Farina, L.;
- Zaja, F.;
- Marcheselli, L.;
- Ferrero, S.;
- Arcaini, L.;
- Pulsoni, A.;
- Musuraca, G.;
- Califano, C.;
- Merli, M.;
- Bari, A.;
- Conconi, A.;
- Giudice, I. del;
- Re, F.;
- Stefani, P. M.;
- Usai, S. V.
Publication type:
Article
ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.130_2880
By:
- Chiappella, A.;
- Carniti, C.;
- Re, A.;
- Castellino, C.;
- Evangelista, A.;
- Ciancia, R.;
- Orsucci, L.;
- Pinto, A.;
- Usai, S. V.;
- Arcari, A.;
- Ilariucci, F.;
- Rossi, F. G.;
- Benedetti, F.;
- Flenghi, L.;
- Ghiggi, C.;
- Molinari, A. L.;
- Stefoni, V.;
- Volpetti, S.;
- Zilioli, V. R.;
- Ballerini, F.
Publication type:
Article

Found: 6

Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas.

RITUXIMAB AND IBRUTINIB COMBINATION IS SAFE AND EFFECTIVE IN UNTREATED SPLENIC AND NODAL MARGINAL ZONE LYMPHOMAS: PLANNED SUBSET ANALYSIS OF THE IELSG47/MALIBU PHASE II STUDY.

Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL).

A RANDOMIZED TRIAL OF OBSERVATION VERSUS RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS WITH COMPLETE METABOLIC RESPONSE AFTER STANDARD IMMUNOCHEMOTHERAPY.

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)

ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY.